People blinded by degenerative eye disease could have some of their sight restored by the first commercial retinal prosthesis. A camera mounted on a pair of glasses feeds an image to an array of 60 electrodes implanted in the wearer’s retina. Although the resulting vision is limited, it’s good enough for recognizing simple objects, finding doors and windows, and, in some cases, even reading large print.
Product: Argus II
Companies: Second Sight
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
The baby formula shortage has birthed a shady online marketplace
Desperate parents just want to feed their babies. They’re having to contend with misinformation, price gouging, and scams along the way.
I tried to buy an Olive Garden NFT. All I got was heartburn.
Our newest issue spells out what you need to know about the dizzying world of digital money.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.